Clenbuterol induces cardiac hypertrophy with normal functional, morphological and molecular features

Cardiovascular Research
K WongMagdi H Yacoub

Abstract

Several pharmacological agents have been shown to produce 'physiological' or 'pathological' hypertrophy based on their functional characteristics. The aim of this study was to examine the features of cardiac hypertrophy induced by the selective beta 2-adrenergic agonist, clenbuterol. Cardiac hypertrophy was induced in 7-week-old Sprague-Dawley rats by daily injections of clenbuterol for 3 weeks. Thyroxine and isoproterenol were also used to produce cardiac hypertrophy to serve as positive controls for physiological and pathological hypertrophy, respectively. Left ventricular function was determined using an isolated rat heart preparation. Ventricular samples were used for morphological examination while interstitial collagen was measured using high-pressure liquid chromatography. Expression of sarcoplasmic reticulum Ca(2+)-ATPase2a (SERCA2a) and phospholamban (PLB) were measured by dot blot analysis. Clenbuterol treatment induced 26% left ventricular hypertrophy. These hearts demonstrated normal systolic isovolumic parameters and diastolic (active relaxation and passive stiffness) function. In addition, left ventricular concentration of collagen and morphology was normal as were the expression of SERCA2a and PLB mRNA. These res...Continue Reading

References

Aug 1, 1979·The Journal of Clinical Investigation·C LiangH Gavras
Jan 1, 1991·Circulation·H E Morgan, K M Baker
Nov 12, 1990·Biochimica Et Biophysica Acta·A M SeymourG K Radda
Apr 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·R NagaiM Periasamy
Sep 1, 1989·Circulation Research·I J BenjaminW A Clark
Jan 1, 1995·Circulation Research·V KuznetsovS F Steinberg
Jan 1, 1994·Journal of Molecular and Cellular Cardiology·P M ButtrickJ Scheuer
Mar 28, 1996·The New England Journal of Medicine·S FazioL Saccà
Sep 1, 1992·Trends in Cardiovascular Medicine·K R Boheler, K Schwartz

❮ Previous
Next ❯

Citations

May 27, 2008·Annals of Biomedical Engineering·Yen-Chih HuangRavi K Birla
Mar 1, 2009·Journal of Cardiovascular Translational Research·Konstantinos G MalliarasJohn N Nanas
Jun 19, 2010·Journal of Cardiovascular Translational Research·James E RiderJennifer L Hall
Jun 19, 2010·Journal of Cardiovascular Translational Research·Enrique Lara-PezziPaul J R Barton
Jun 26, 2010·Journal of Cardiovascular Translational Research·Pankaj K BhavsarPaul J R Barton
Sep 2, 2000·The Annals of Thoracic Surgery·C C GrayM H Yacoub
Jul 4, 2002·Comparative Biochemistry and Physiology. Part A, Molecular & Integrative Physiology·Edward G Lakatta, Steven J Sollott
Nov 3, 2006·The New England Journal of Medicine·Emma J BirksMagdi H Yacoub
Jan 12, 2010·Annual Review of Medicine·Cesare M TerraccianoMagdi H Yacoub
Sep 9, 2008·American Journal of Physiology. Heart and Circulatory Physiology·U SiedleckaC M N Terracciano
Feb 5, 2014·Current Treatment Options in Cardiovascular Medicine·Andrew J Lenneman, Emma J Birks
Oct 7, 2008·Pharmacology & Therapeutics·James G Ryall, Gordon S Lynch
Aug 29, 2007·Heart Failure Clinics·Johannes Mueller, Gerd Wallukat
Apr 21, 2006·Journal of Cardiac Failure·Daniel BurkhoffDonna M Mancini
Aug 28, 1999·Journal of Toxicology. Clinical Toxicology·T Y Chan
Jun 16, 2010·Journal of Cardiac Surgery·Emma J Birks
Jul 13, 2013·The International Journal of Biochemistry & Cell Biology·Olivier R JoassardDamien G Freyssenet
Apr 14, 2012·The Journal of Thoracic and Cardiovascular Surgery·Emma J BirksAsghar Khaghani
Jun 1, 2001·The Journal of Thoracic and Cardiovascular Surgery·C C GrayM H Yacoub
Sep 2, 2016·High Altitude Medicine & Biology·Enrico DoneganiDavid Hillebrandt
May 29, 2013·Anesthesiology Clinics·Michelle Capdeville, Nicholas G Smedira
May 11, 2007·Expert Review of Cardiovascular Therapy·James O Mudd, David A Kass
May 11, 2007·Expert Review of Cardiovascular Therapy·Stavros G DrakosJohn N Nanas
Apr 13, 2004·Current Opinion in Cardiology·Emma J BirksAsghar Khaghani
Nov 6, 2004·American Journal of Physiology. Heart and Circulatory Physiology·Gopal K R SoppaMagdi H Yacoub
Oct 12, 2018·Heart Failure Reviews·Binh N Pham, Sandra V Chaparro
Sep 1, 2011·Expert Review of Cardiovascular Therapy·Fiona HatchSandra A Jones
Nov 30, 2018·ASAIO Journal : a Peer-reviewed Journal of the American Society for Artificial Internal Organs·Jae Hwan ChoiVakhtang Tchantchaleishvili
Jan 7, 2016·ASAIO Journal : a Peer-reviewed Journal of the American Society for Artificial Internal Organs·Kevin PhanVakhtang Tchantchaleishvili
May 10, 2011·Medicine and Science in Sports and Exercise·Guglielmo DurantiDaniela Caporossi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiomegaly

Cardiomegaly, known as an enlarged heart, is a multifactorial disease with different pathophysiological mechanisms. Hypertension, pregnancy, exercise-induced and idiopathic causes are some mechanisms of cardiomegaly. Discover the latest research of cardiomegaly here.